2025-01-17 21:56:55
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China
Corporate/ 2023-07-23
Bridge Biotherapeutics Announces Initiat...

China Phase I study of BBT-401 had its first subject dosed in Chengdu,China The company seeks to accelerate its business development activit...

CStone received China NMPA IND acceptance for lorlatinib in Chinese patients with ROS1-positive advanced NSCLC
Corporate/ 2023-07-23
CStone received China NMPA IND acceptanc...

SUZHOU,China,Oct. 20,2021-- CStone Pharmaceuticals ("CStone",HKEX: 2616),a leading biopharmaceutical company focused on researchin...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release